 double-blind placebo-control trial nimodipin acut stroke trust studi group valu oral nimodipin mg day acut stroke randomis double-blind placebo-control multicentr studi patient primari end-point independ month score activ daili live adl scale barthel index patient trial hemiparet previou consciou abl stroke month nimodipin group placebo group independ odd ratio independ nimodipin confid limit mortal odd nimodipin confid limit adl neurolog score delay recoveri nimodipin group week result case oral nimodipin therapi mg day stroke patient acut stroke